Meropenem Aptapharma

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats serious bacterial infections such as intra‑abdominal, urinary tract, and hospital‑acquired pneumonias in hospitalized patients. GNH USA supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat severe bacterial infections in the hospital setting.

Complicated intra‑abdominal infections: provides rapid bacterial eradication in severe abdominal sepsis. Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis. Hospital‑acquired pneumonia: effective against multidrug‑resistant organisms in lung infections. Ventilator‑associated pneumonia: targets pathogens common in ventilated patients. Septicemia: offers bactericidal activity for bloodstream infections.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limited. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Infusion site reactions: pain or erythema at the injection site. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with CNS disorders or renal impairment. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Anaphylaxis: acute allergic reaction requiring emergency care. - Severe renal toxicity: acute kidney injury in susceptible individuals. - Neutropenia: marked reduction in white blood cells. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Meropenem should be used with caution in specific clinical situations. - Renal impairment: adjust dosage based on creatinine clearance. - CNS disorders: monitor for seizures, especially in patients with a history of epilepsy. - Hypersensitivity: avoid in patients with known carbapenem or beta‑lactam allergy. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Concomitant nephrotoxic drugs: monitor renal function closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Valproic acid: meropenem can reduce plasma concentrations, increasing seizure risk. - Probenecid: may increase meropenem levels, raising toxicity potential. - Other carbapenems: concurrent use can amplify adverse effects.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxicity; monitor renal function. - Loop diuretics: may enhance renal effects. - NSAIDs: increase risk of kidney injury. - Warfarin: monitor INR for possible anticoagulant effect changes. - Oral contraceptives: possible reduction in efficacy; advise alternative contraception.